Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis (review)

Molecular Medicine Reports

Volumn 9, Issue 5, 2014, Pages 1483-1505

  Kobayashi, Hiroshi ^a   Imanaka, Shogo ^a   Nakamura, Haruki ^a   Tsuji, Ayumi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Endometriosis; Environment; Epigenetic; Genetic

Indexed keywords

COMPLEMENT COMPONENT C3; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DIPEPTIDYL CARBOXYPEPTIDASE; FETUIN A; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; HLA DQB1 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; MATRILYSIN; MITOCHONDRIAL DNA; MUCIN 2; MUCIN 4; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; STAT6 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UVOMORULIN; VASCULOTROPIN;

CANCER GROWTH; CARCINOGENESIS; CHROMOSOMAL INSTABILITY; COPY NUMBER VARIATION; ENDOMETRIOSIS; ENVIRONMENTAL CHANGE; EPIGENETICS; FENTON REACTION; GENE DOSAGE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOMIC INSTABILITY; GENOMICS; HAPLOTYPE; HETEROZYGOSITY LOSS; HUMAN; IRON OVERLOAD; MALIGNANT TRANSFORMATION; MENSTRUATION; MICROENVIRONMENT; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; OXIDATIVE STRESS; PHENOTYPE; PROGENY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR PROMOTION;

CELL TRANSFORMATION, NEOPLASTIC; DNA, MITOCHONDRIAL; ENDOMETRIOSIS; EPIGENESIS, GENETIC; FEMALE; GENETIC VARIATION; GENOMIC INSTABILITY; GENOMICS; HAPLOTYPES; HUMANS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84899512132     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2057     Document Type: Review

References (246)

1. Forte A, Cipollaro M and Galderisi U: Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives. Clin Sci (Lond) 126: 123-138, 2014.
2. Kobayashi H, Yamada Y, Kanayama S, et al: The role of iron in the pathogenesis of endometriosis. Gynecol Endocrinol 25: 39-52, 2009.
3. Munksgaard PS and Blaakaer J: The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecol Oncol 124: 164-169, 2012.
4. Vlahos NF, Kalampokas T and Fotiou S: Endometriosis and ovarian cancer: a review. Gynecol Endocrinol 26: 213-219, 2010.
5. Congrains A, Kamide K, Ohishi M and Rakugi H: ANRIL: molecular mechanisms and implications in human health. Int J Mol Sci 14: 1278-1292, 2013.
6. Guo SW: Epigenetics of endometriosis. Mol Hum Reprod 15: 587-607, 2009.
7. Van Langendonckt A, Casanas-Roux F and Donnez J: Oxidative stress and peritoneal endometriosis. Fertil Steril 77: 861-870, 2002. (Pubitemid 34497149)
8. Oner-Iyidoǧan Y, Koçak H, Gürdöl F, Korkmaz D and Buyru F: Indices of oxidative stress in eutopic and ectopic endometria of women with endometriosis. Gynecol Obstet Invest 57: 214-217, 2004.
9. Ngô C, Chéreau C, Nicco C, Weill B, Chapron C and Batteux F: Reactive oxygen species controls endometriosis progression. Am J Pathol 175: 225-234, 2009.
10. Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C and Nezhat C: The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril 90: 1559-1570, 2008.
11. Kennedy S: Genetics of endometriosis: a review of the positional cloning approaches. Semin Reprod Med 21: 111-118, 2003.
12. Spuijbroek MD, Dunselman GA, Menheere PP and Evers JL: Early endometriosis invades the extracellular matrix. Fertil Steril 58: 929-933, 1992.
13. Worley MJ, Welch WR, Berkowitz RS and Ng SW: Endometriosis-associated ovarian cancer: a review of pathogenesis. Int J Mol Sci 14: 5367-5379, 2013.
14. Higashiura Y, Kajihara H, Shigetomi H and Kobayashi H: Identification of multiple pathways involved in the malignant transformation of endometriosis (Review). Oncol Lett 4: 3-9, 2012.
15. Mao TL and Shih IM: The roles of ARID1A in gynecologic cancer. J Gynecol Oncol 24: 376-381, 2013.
16. Yamamoto S, Tsuda H, Takano M, Iwaya K, Tamai S and Matsubara O: PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma. J Pathol 225: 189-194, 2011.
17. Samartzis EP, Noske A, Dedes KJ, Fink D and Imesch P: ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci 14: 18824-1849, 2013.
18. Maeda D and Shih IeM: Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 20: 45-52, 2013.
19. Wiegand KC, Shah SP, Al-Agha OM, et al: ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363: 1532-1543, 2010.
20. Amemiya S, Sekizawa A, Otsuka J, Tachikawa T, Saito H and Okai T: Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability. Int J Gynaecol Obstet 86: 371-376, 2004. (Pubitemid 39119945)
21. Nakayama K, Toki T, Nikaido T, Zhai YL and Konishi I: Genetic alterations in microsatellite marker sites among tumor suppressor genes in endometriosis. Gynecol Obstet Invest 51: 240-242, 2001. (Pubitemid 32620122)
22. Fuseya C, Horiuchi A, Hayashi A, et al: Involvement of pelvic inflammation-related mismatch repair abnormalities and micro-satellite instability in the malignant transformation of ovarian endometriosis. Hum Pathol 43: 1964-1972, 2012.
23. Ali-Fehmi R, Khalifeh I, Bandyopadhyay S, et al: Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis. Int J Gynecol Pathol 25: 223-229, 2006. (Pubitemid 44610034)
24. Gogusev J, Bouquet de Jolinière J, Telvi L, et al: Genetic abnormalities detected by comparative genomic hybridization in a human endometriosis-derived cell line. Mol Hum Reprod 6: 821-827, 2000.
25. Yang W, Zhang Y, Fu F and Li R: High-resolution array-comparative genomic hybridization profiling reveals 20q13.33 alterations associated with ovarian endometriosis. Gynecol Endocrinol 29: 603-607, 2013.
26. Saare M, Sõritsa D, Vaidla K, et al: No evidence of somatic DNA copy number alterations in eutopic and ectopic endometrial tissue in endometriosis. Hum Reprod 27: 1857-1864, 2012.
27. Sato N, Tsunoda H, Nishida M, et al: Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60: 7052-7056, 2000. (Pubitemid 32059184)
28. Obata K and Hoshiai H: Common genetic changes between endometriosis and ovarian cancer. Gynecol Obstet Invest 50 (Suppl 1): 39-43, 2000.
29. Xu B, Hamada S, Kusuki I, Itoh R and Kitawaki J: Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis. Gynecol Oncol 120: 239-246, 2011.
30. Thomas EJ and Campbell IG: Molecular genetic defects in endometriosis. Gynecol Obstet Invest 50 (Suppl 1): 44-50, 2000.
31. Painter JN, Anderson CA, Nyholt DR, et al: Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet 43: 51-54, 2011.
32. Jiang X, Hitchcock A, Bryan EJ, et al: Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res 56: 3534-3539, 1996. (Pubitemid 26251649)
33. Silveira CG, Abrão MS, Dias JA Jr, et al: Common chromosomal imbalances and stemness-related protein expression markers in endometriotic lesions from different anatomical sites: the potential role of stem cells. Hum Reprod 27: 3187-3197, 2012.
34. Son JW, Jeong KJ, Jean WS, et al: Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients. Cancer Lett 311: 29-37, 2011.
35. Goumenou AG, Arvanitis DA, Matalliotakis IM, Koumantakis EE and Spandidos DA: Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis. Fertil Steril 75: 160-165, 2001. (Pubitemid 32041239)
36. Govatati S, Kodati VL, Deenadayal M, Chakravarty B, Shivaji S and Bhanoori M: Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study. Hum Reprod 29: 324-336, 2014.
37. Dun EC, Taylor RN and Wieser F: Advances in the genetics of endometriosis. Genome Med 2: 75, 2010.
38. Kurman RJ and Shih IeM: The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34: 433-443, 2010.
39. Noack F, Schmidt H, Buchweitz O, Malik E and Horny HP: Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst. Anticancer Res 24: 151-154, 2004. (Pubitemid 38279701)
40. Pellegrini C, Gori I, Achtari C, et al: The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis. Fertil Steril 98: 1200-1208, 2012.
41. Catasús L, Bussaglia E, Rodrguez I, et al: Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Hum Pathol 35: 1360-1368, 2004.
42. Stewart CJ, Walsh MD, Budgeon CA, Crook ML and Buchanan DB: Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis. Pathology 45: 559-566, 2013.
43. Shaco-Levy R, Sharabi S, Benharroch D, Piura B and Sion-Vardy N: Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Eur J Obstet Gynecol Reprod Biol 139: 226-232, 2008.
44. Hadjihannas MV and Behrens J: CIN By WNT: growth pathways, mitotic control and chromosomal instability in cancer. Cell Cycle 5: 2077-2081, 2006. (Pubitemid 44553742)
45. Bau DT, Hsieh YY, Wan L, et al: Polymorphism of XRCC1 codon arg 399 Gln is associated with higher susceptibility to endometriosis. Chin J Physiol 50: 326-329, 2007.
46. Hsieh YY, Bau DT, Chang CC, Tsai CH, Chen CP and Tsai FJ: XRCC4 codon 247&z.ast;A and XRCC4 promoter -1394&z.ast;T related genotypes but not XRCC4 intron 3 gene polymorphism are associated with higher susceptibility for endometriosis. Mol Reprod Dev 75: 946-951, 2008. (Pubitemid 351438960)
47. Carvalho LF, Abrão MS, Biscotti C, Sharma R, Nutter B and Falcone T: Oxidative cell injury as a predictor of endometriosis progression. Reprod Sci 20: 688-698, 2013.
48. Miao J, Zhang X, Tang QL, Wang XY and Kai L: Prediction value of XRCC 1 gene polymorphism on the survival of ovarian cancer treated by adjuvant chemotherapy. Asian Pac J Cancer Prev 13: 5007-5010, 2012.
49. Sáinz de la Cuesta R, Izquierdo M, Cañamero M, Granizo JJ and Manzarbeitia F: Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis. Eur J Obstet Gynecol Reprod Biol 113: 87-93, 2004.
50. Fauvet R, Poncelet C, Hugol D, Lavaur A, Feldmann G and Daraï E: Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours. Virchows Arch 443: 38-43, 2003.
51. Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P and Kalir T: Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 94: 2935-2940, 2002. (Pubitemid 34547693)
52. Kim SH, Choi YM, Lee GH, et al : Association between susceptibility to advanced stage endometriosis and the genetic polymorphisms of aryl hydrocarbon receptor repressor and glutathione-S-transferase T1 genes. Hum Reprod 22: 1866-1870, 2007. (Pubitemid 47064318)
53. Cramer DW, Hornstein MD, Ng WG and Barbieri RL: Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT). Mol Hum Reprod 2: 149-152, 1996. (Pubitemid 126719014)
54. Stefansson H, Einarsdottir A, Geirsson RT, et al: Endometriosis is not associated with or linked to the GALT gene. Fertil Steril 76: 1019-1022, 2001. (Pubitemid 33031331)
55. He C, Song Y, He X, Zhang W and Liao L: No association of endometriosis with galactose-1-phosphate uridyl transferase mutations in a Chinese population. Environ Mol Mutagen 47: 307-309, 2006.
56. Babu KA, Reddy NG, Deendayal M, Kennedy S and Shivaji S: GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women. Pharmacogenet Genomics 15: 167-172, 2005. (Pubitemid 40569903)
57. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Chen JM and Tsai CH: Glutathione S-transferase M1&z.ast;null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis. Mol Hum Reprod 10: 713-717, 2004. (Pubitemid 39341593)
58. Arvanitis DA, Goumenou AG, Matalliotakis IM, Koumantakis EE and Spandidos DA: Low-penetrance genes are associated with increased susceptibility to endometriosis. Fertil Steril 76: 1202-1206, 2001. (Pubitemid 33116387)
59. Baranova H, Canis M, Ivaschenko T, et al: Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 genes in the development of endometriosis. Mol Hum Reprod 5: 636-641, 1999. (Pubitemid 29317753)
60. Baranova H, Bothorishvilli R, Canis M, et al: Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population. Mol Hum Reprod 3: 775-780, 1997. (Pubitemid 127509611)
61. Wu CH, Guo CY, Yang JG, et al: Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population. Am J Reprod Immunol 67: 160-168, 2012.
62. Nakago S, Hadfield RM, Zondervan KT, et al: Association between endometriosis and N-acetyl transferase 2 polymorphisms in a UK population. Mol Hum Reprod 7: 1079-1083, 2001. (Pubitemid 33048780)
63. Vestergaard AL, Thorup K, Knudsen UB, et al: Oncogenic events associated with endometrial and ovarian cancers are rare in endometriosis. Mol Hum Reprod 17: 758-761, 2011.
64. Nakayama K, Toki T, Zhai YL, et al: Demonstration of focal p53 expression without genetic alterations in endometriotic lesions. Int J Gynecol Pathol 20: 227-231, 2001. (Pubitemid 32578107)
65. Akahane T, Sekizawa A, Purwosunu Y, Nagatsuka M and Okai T: The role of p53 mutation in the carcinomas arising from endometriosis. Int J Gynecol Pathol 26: 345-351, 2007. (Pubitemid 46986074)
66. Stewart CJ, Leung Y, Walsh MD, Walters RJ, Young JP and Buchanan DD: KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis. Hum Pathol 43: 1177-1183, 2012.
67. Christie M and Oehler MK: Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc 12: 57-63, 2006. (Pubitemid 43881064)
68. Willner J, Wurz K, Allison KH, et al: Alternate molecular genetic pathways in ovarian carcinomas of common histological types. Hum Pathol 38: 607-613, 2007. (Pubitemid 46399888)
69. Yamamoto S, Tsuda H, Honda K, et al: ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas. Histopathology 60: 1073-1083, 2012.
70. Wu RC, Ayhan A, Maeda D, et al: Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. J Pathol 232: 473-481, 2014.
71. Prefumo F, Venturini PL and Fulcheri E: Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis. Int J Gynecol Pathol 22: 83-88, 2003. (Pubitemid 36014281)
72. Ying TH, Tseng CJ, Tsai SJ, et al: Association of p53 and CDKN1A genotypes with endometriosis. Anticancer Res 31: 4301-4306, 2011.
73. Skirnisdottir I and Seidal T: Association of p21, p21/p27 and p21/p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer. Cancer Genomics Proteomics 10: 27-34, 2013.
74. Lee YH, Heo JH, Kim TH, et al: Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Int J Gynecol Pathol 30: 205-217, 2011.
75. Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S and Matsubara O: Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas. Mod Pathol 25: 122-130, 2012.
76. Otsuka J, Okuda T, Sekizawa A, et al: K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma. Med Electron Microsc 37: 188-192, 2004.
77. Govatati S, Deenadayal M, Shivaji S and Bhanoori M: Mitochondrial displacement loop alterations are associated with endometriosis. Fertil Steril 99: 1980-1986.e9, 2013.
78. Hsu CC, Lee HC and Wei YH: Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma. World J Gastroenterol 19: 8880-8886, 2013.
79. Govatati S, Tipirisetti NR, Perugu S, et al: Mitochondrial genome variations in advanced stage endometriosis: a study in South Indian population. PLoS One 7: e40668, 2012.
80. Cho S, Lee YM, Choi YS, et al: Mitochondria DNA polymorphisms are associated with susceptibility to endometriosis. DNA Cell Biol 31: 317-322, 2012.
81. Kao SH, Huang HC, Hsieh RH, Chen SC, Tsai MC and Tzeng CR: Oxidative damage and mitochondrial DNA mutations with endometriosis. Ann NY Acad Sci 1042: 186-194, 2005.
82. Colón-Díaz M, Báez-Vega P, García M, et al: HDAC1 and HDAC2 are differentially expressed in endometriosis. Reprod Sci 19: 483-492, 2012.
83. Cakmak H and Taylor HS: Implantation failure: molecular mechanisms and clinical treatment. Hum Reprod Update 17: 242-253, 2011.
84. Nasu K, Kawano Y, Tsukamoto Y, et al: Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target. J Obstet Gynaecol Res 37: 683-695, 2011.
85. Kawano Y, Nasu K, Li H, et al: Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod 26: 2486-2498, 2011.
86. Wu Y, Strawn E, Basir Z, Halverson G and Guo SW: Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 87: 24-32, 2007. (Pubitemid 46013877)
87. Izawa M, Taniguchi F, Terakawa N and Harada T: Epigenetic aberration of gene expression in endometriosis. Front Biosci (Elite Ed) 5: 900-910, 2013.
88. Khan MA, Sengupta J, Mittal S and Ghosh D: Genome-wide expressions in autologous eutopic and ectopic endometrium of fertile women with endometriosis. Reprod Biol Endocrinol 10: 84, 2012.
89. Kobayashi H, Uekuri C and Shigetomi H: Towards an understanding of the molecular mechanism of endometriosis: unbalancing epithelial-stromal genetic conflict. Gynecol Endocrinol 30: 7-15, 2014.
90. Peltomäki P and Bützow R: Pathogenesis of endometriosis and its relationship to gynecological cancers. Epigenomics 3: 689-690, 2011.
91. Tiberi F, Tropea A, Romani F, Apa R, Marana R and Lanzone A: Prokineticin 1, homeobox A10, and progesterone receptor messenger ribonucleic acid expression in primary cultures of endometrial stromal cells isolated from endometrium of healthy women and from eutopic endometrium of women with endometriosis. Fertil Steril 94: 2558-2563, 2010.
92. Vinatier D, Cosson M and Dufour P: Is endometriosis an endometrial disease? Eur J Obstet Gynecol Reprod Biol 91: 113-125, 2000. (Pubitemid 30408318)
93. Nyholt DR, Low SK, Anderson CA, et al: Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet 44: 1355-1359, 2012.
94. Calicchio R, Doridot L, Miralles F, Méhats C and Vaiman D: DNA methylation, an epigenetic mode of gene expression regulation in reproductive science. Curr Pharm Des: Jul 19, 2013 (Epub ahead of print).
95. Kobayashi H, Iwai K, Niiro E, Morioka S and Yamada Y: Fetal programming theory: Implication for the understanding of endometriosis. Hum Immunol 75: 208-217, 2014.
96. McCarty CA, Berg RL, Welter JD, Kitchner TE and Kemnitz JW: A novel gene-environment interaction involved in endometriosis. Int J Gynaecol Obstet 116: 61-63, 2012.
97. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Michels KB and Hunter DJ: In utero exposures and the incidence of endometriosis. Fertil Steril 82: 1501-1508, 2004. (Pubitemid 39611373)
98. Parazzini F, Cipriani S, Bravi F, et al: A metaanalysis on alcohol consumption and risk of endometriosis. Am J Obstet Gynecol 209: 106.e1-e10, 2013.
99. Andolf E, Thorsell M and Källén K: Caesarean section and risk for endometriosis: a prospective cohort study of Swedish registries. BJOG 120: 1061-1065, 2013.
100. Kvaskoff M, Bijon A, Clavel-Chapelon F, Mesrine S and Boutron-Ruault MC: Childhood and adolescent exposures and the risk of endometriosis. Epidemiology 24: 261-269, 2013.
101. Missmer SA, Chavarro JE, Malspeis S, et al: A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod 25: 1528-535, 2010.
102. Vitonis AF, Baer HJ, Hankinson SE, Laufer MR and Missmer SA: A prospective study of body size during childhood and early adulthood and the incidence of endometriosis. Hum Reprod 25: 1325-1334, 2010.
103. Guo SW, Simsa P, Kyama CM, et al: Reassessing the evidence for the link between dioxin and endometriosis: from molecular biology to clinical epidemiology. Mol Hum Reprod 15: 609-624, 2009.
104. Marino JL, Holt VL, Chen C and Davis S: Lifetime occupational history and risk of endometriosis. Scand J Work Environ Health 35: 233-240, 2009.
105. Nagle CM, Bell TA, Purdie DM, et al: Relative weight at ages 10 and 16 years and risk of endometriosis: a case-control analysis. Hum Reprod 24: 1501-1506, 2009.
106. Kavoussi SK, West BT, Taylor GW and Lebovic DI: Periodontal disease and endometriosis: analysis of the National Health and Nutrition Examination Survey. Fertil Steril 91: 335-342, 2009.
107. Buck Louis GM, Hediger ML and Peña JB: Intrauterine exposures and risk of endometriosis. Hum Reprod 22: 3232-3236, 2007.
108. Kvaskoff M, Mesrine S, Clavel-Chapelon F and Boutron-Ruault MC: Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: the French E3N cohort. Int J Epidemiol 38: 1143-1, 2009.
109. Kobayashi H, Higashiura Y, Shigetomi H and Kajihara H: Pathogenesis of endometriosis: The role of initial infection and subsequent sterile inflammation (Review). Mol Med Rep 9: 9-15, 2014.
110. Prá D, Franke SI, Henriques JA and Fenech M: Iron and genome stability: an update. Mutat Res 733: 92-99, 2012.
111. Yamada Y, Shigetomi H, Onogi A, et al: Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer 21: 1200-1207, 2011.
112. Loi M, Del Savio L and Stupka E: Social epigenetics and equality of opportunity. Public Health Ethics 6: 142-153, 2013.
113. Yara S, Lavoie JC, Beaulieu JF, et al: Iron-ascorbate-mediated lipid peroxidation causes epigenetic changes in the antioxidant defense in intestinal epithelial cells: impact on inflammation. PLoS One 8: e63456, 2013.
114. Kim HY, Cho S, Choi YS, et al: Cyclooxygenase-2 (COX-2) gene-765G/C polymorphism and advanced-stage endometriosis in Korean women. Am J Reprod Immunol 68: 238-243, 2012.
115. Barbosa CP, Teles JS, Lerner TG, et al: Genetic association study of polymorphisms FOXP3 and FCRL3 in women with endometriosis. Fertil Steril 97: 1124-1128, 2012.
116. Bianco B, Teles JS, Lerner TG, Vilarino FL, Christofolini DM and Barbosa CP: Association of FCRL3 -169T/C polymorphism with endometriosis and identification of a protective haplotype against the development of the disease in Brazilian population. Hum Immunol 72: 774-778, 2011.
117. Teles JS, Bianco B, Vilarino FL, André GM, Christofolini DM and Barbosa CP: Association of FCRL3 C-169T promoter single-nucleotide polymorphism with idiopathic infertility and infertility-related endometriosis. J Reprod Immunol 89: 212-215, 2011.
118. Kitawaki J, Koshiba H, Kitaoka Y, et al: Interferon-gamma gene dinucleotide (CA) repeat and interleukin-4 promoter region (-590C/T) polymorphisms in Japanese patients with endometriosis. Hum Reprod 19: 1765-1769, 2004. (Pubitemid 39144619)
119. Kim JJ, Choi YM, Hwang SS, et al: Association of the interferon- γ gene (CA)n repeat polymorphism with endometriosis. BJOG 118: 1061-1066, 2011.
120. Rozati R, Vanaja MC and Nasaruddin K: Genetic contribution of the interferon gamma dinucleotide-repeat polymorphism in South Indian women with endometriosis. J Obstet Gynaecol Res 36: 825-831, 2010.
121. Adachi S, Tajima A, Quan J, et al: Meta-analysis of genome-wide association scans for genetic susceptibility to endometriosis in Japanese population. J Hum Genet 55: 816-821, 2010.
122. Gallegos-Arreola MP, Figuera-Villanueva LE, Puebla-Pérez AM, Montoya-Fuentes H, Suarez-Rincon AE and Zúñiga-González GM: Association of TP53 gene codon 72 polymorphism with endometriosis in Mexican women. Genet Mol Res 11: 1401-1408, 2012.
123. D'Amora P, Sato H, Girão MJ, Silva ID and Schor E: Polymorphisms in exons 1B and 1C of the type I interleukin-1 receptor gene in patients with endometriosis. Am J Reprod Immunol 56: 178-184, 2006. (Pubitemid 44159215)
124. Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin CC and Tsai CH: Interleukin-2 receptor beta (IL-2R beta)-627&z.ast;C homozygote but not IL-12R beta 1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis. Fertil Steril 84: 510-512, 2005. (Pubitemid 41125282)
125. Li J, Chen Y, Wei S, et al: Tumor necrosis factor and interleukin-6 gene polymorphisms and endometriosis risk in Asians: a systematic review and meta-analysis. Ann Hum Genet: Dec 6, 2013 (Epub ahead of print).
126. Kitawaki J, Kiyomizu M, Obayashi H, et al: Synergistic effect of interleukin-6 promoter (IL6 -634C/G) and intercellular adhesion molecule-1 (ICAM-1 469K/E) gene polymorphisms on the risk of endometriosis in Japanese women. Am J Reprod Immunol 56: 267-274, 2006. (Pubitemid 44288656)
127. Fan W, Li S, Chen Q, Huang Z, Ma Q and Xiao Z: Association between interleukin-10 promoter polymorphisms and endometriosis: a meta-analysis. Gene 515: 49-55, 2013.
128. Riiskjaer M, Nielsen K, Steffensen R, Erikstrup C, Forman A and Kruse C: Association of interleukin-10 promoter polymorphism and endometriosis. Am J Reprod Immunol 65: 13-19, 2011.
129. Juo SH, Wu R, Lin CS, Wu MT, Lee JN and Tsai EM: A functional promoter polymorphism in interleukin-10 gene influences susceptibility to endometriosis. Fertil Steril 92: 1228-1233, 2009.
130. Xie J, Wang S, He B, et al: Association of estrogen receptor alpha and interleukin-10 gene polymorphisms with endometriosis in a Chinese population. Fertil Steril 92: 54-60, 2009.
131. Zhang X, Hei P, Deng L and Lin J: Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis. Mol Hum Reprod 13: 135-140, 2007. (Pubitemid 46152600)
132. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tai CT and Ho M: Association of an A allele for interleukin-10 -627 gene promoter polymorphism with higher susceptibility to endometriosis. J Reprod Med 48: 735-738, 2003.
133. Kitawaki J, Obayashi H, Ohta M, et al: Genetic contribution of the interleukin-10 promoter polymorphism in endometriosis susceptibility. Am J Reprod Immunol 47: 12-18, 2002. (Pubitemid 34552369)
134. Gan XL, Lin YH, Zhang Y, Yu TH and Hu LN: Association of an interleukin-16 gene polymorphism with the risk and pain phenotype of endometriosis. DNA Cell Biol 29: 663-667, 2010.
135. Ayaz L, Çelik SK, Çayan F, Aras-Ateş N and Tamer L: Functional association of interleukin-18 gene -607 C/A promoter polymorphisms with endometriosis. Fertil Steril 95: 298-300, 2011.
136. Kitawaki J, Xu B, Ishihara H, et al: Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis. Am J Reprod Immunol 58: 481-486, 2007. (Pubitemid 350091184)
137. Bianco B, Lerner TG, Trevisan CM, Cavalcanti V, Christofolini DM and Barbosa CP: The nuclear factor-κB functional promoter polymorphism is associated with endometriosis and infertility. Hum Immunol 73: 1190-1193, 2012.
138. Zhou B, Rao L, Peng Y, et al: A functional promoter polymorphism in NFKB1 increases susceptibility to endometriosis. DNA Cell Biol 29: 235-239, 2010.
139. Kim H, Ku SY, Kim SH, et al: Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with advanced stage endometriosis. Hum Reprod 24: 2656-2659, 2009.
140. Lakshmi KV, Shetty P, Vottam K, Govindhan S, Ahmad SN and Hasan Q: Tumor necrosis factor alpha -C850T polymorphism is significantly associated with endometriosis in Asian Indian women. Fertil Steril 94: 453-456, 2010.
141. Chae SJ, Kim H, Jee BC, Suh CS, Kim SH and Kim JG: Tumor necrosis factor (TNF)-TNF receptor gene polymorphisms and their serum levels in Korean women with endometriosis. Am J Reprod Immunol 60: 432-439, 2008.
142. Lee GH, Choi YM, Kim SH, et al: Association of tumor necrosis factor-{alpha} gene polymorphisms with advanced stage endometriosis. Hum Reprod 23: 977-981, 2008.
143. Asghar T, Yoshida S, Kennedy S, et al: The tumor necrosis factor-alpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 19: 2509-2514, 2004. (Pubitemid 39481275)
144. Teramoto M, Kitawaki J, Koshiba H, et al: Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol 51: 352-357, 2004. (Pubitemid 38765269)
145. Christofolini DM, Cavalheiro CM, Teles JS, et al: Promoter -817C>T variant of B lymphocyte stimulator gene (BLyS) and susceptibility to endometriosis-related infertility and idiopathic infertility in Brazilian population. Scand J Immunol 74: 628-631, 2011.
146. Lee HJ, Kim H, Ku SY, Kim SH and Kim JG: Transforming growth factor-β1 gene polymorphisms in Korean women with endometriosis. Am J Reprod Immunol 66: 428-434, 2011.
147. Hsieh YY, Chang CC, Tsai FJ, Peng CT, Yeh LS and Lin CC: Polymorphism for transforming growth factor beta 1-509 (TGF-B1-509): association with endometriosis. Biochem Genet 43: 203-210, 2005.
148. Latha M, Vaidya S, Movva S, et al: Molecular pathogenesis of endometriosis; Toll-like receptor-4 A896G (D299G) polymorphism: a novel explanation. Genet Test Mol Biomarkers 15: 181-184, 2011.
149. Tsuchiya M, Tsukino H, Iwasaki M, et al: Interaction between cytochrome P450 gene polymorphisms and serum organochlorine TEQ levels in the risk of endometriosis. Mol Hum Reprod 13: 399-404, 2007. (Pubitemid 47078737)
150. Cayan F, Ayaz L, Aban M, Dilek S and Gümüş LT: Role of CYP2C19 polymorphisms in patients with endometriosis. Gynecol Endocrinol 25: 530-535, 2009.
151. Szczepańska M, Wirstlein P, Skrzypczak J and Jagodziński PP: Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis. Acta Obstet Gynecol Scand 92: 1188-1193, 2013.
152. Bozdag G, Alp A, Saribas Z, Tuncer S, Aksu T and Gurgan T: CYP17 and CYP2C19 gene polymorphisms in patients with endometriosis. Reprod Biomed Online 20: 286-290, 2010.
153. Hsieh YY, Chang CC, Tsai FJ, Lin CC and Tsai CH: Estrogen receptor alpha dinucleotide repeat and cytochrome P450c17alpha gene polymorphisms are associated with susceptibility to endometriosis. Fertil Steril 83: 567-572, 2005. (Pubitemid 40348565)
154. Hsieh YY, Chang CC, Tsai FJ, Lin CC and Tsai CH: Cytochrome P450c17alpha 5′-untranslated region &z.ast;T/C polymorphism in endometriosis. J Genet 83: 189-192, 2004. (Pubitemid 39539979)
155. Wang HS, Wu HM, Cheng BH, et al: Functional analyses of endometriosis-related polymorphisms in the estrogen synthesis and metabolism-related genes. PLoS One 7: e47374, 2012.
156. Trabert B, Schwartz SM, Peters U, et al: Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes. Fertil Steril 96: 1401-1406.e3, 2011.
157. Vietri MT, Cioffi M, Sessa M, et al: CYP17 and CYP19 gene polymorphisms in women affected with endometriosis. Fertil Steril 92: 1532-1535, 2009.
158. Kado N, Kitawaki J, Obayashi H, et al: Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 17: 897-902, 2002. (Pubitemid 34411118)
159. Ertunc D, Aban M, Tok EC, Tamer L, Arslan M and Dilek S: Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis. Hum Reprod 20: 2157-2161, 2005. (Pubitemid 41418499)
160. Tsuchiya M, Katoh T, Motoyama H, Sasaki H, Tsugane S and Ikenoue T: Analysis of the AhR, ARNT, and AhRR gene polymorphisms: genetic contribution to endometriosis susceptibility and severity. Fertil Steril 84: 454-458, 2005. (Pubitemid 41125269)
161. Shaik NA, Govindan S, Kodati V, Rao KP and Hasan Q: Polymorphic (CAG)n repeats in the androgen receptor gene: a risk marker for endometriosis and uterine leiomyomas. Hematol Oncol Stem Cell Ther 2: 289-293, 2009.
162. Bilibio JP, Matte U, de Conto E, Genro VK, Souza CA and Cunha-Filho JS: Dopamine receptor D2 genotype (3438) is associated with moderate/severe endometriosis in infertile women in Brazil. Fertil Steril 99: 1340-1345, 2013.
163. Govindan S, Shaik NA, Vedicherla B, Kodati V, Rao KP and Hasan Q: Estrogen receptor-alpha gene (T/C) Pvu II polymorphism in endometriosis and uterine fibroids. Dis Markers 26: 149-154, 2009.
164. Wang W, Li Y, Maitituoheti M, Yang R, et al: Association of an oestrogen receptor gene polymorphism in Chinese Han women with endometriosis and endometriosis-related infertility. Reprod Biomed Online 26: 93-98, 2013.
165. Lamp M, Peters M, Reinmaa E, et al: Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis. Gynecol Endocrinol 27: 425-433, 2011.
166. Hsieh YY, Wang YK, Chang CC and Lin CS: Estrogen receptor alpha-351 XbaI&z.ast;G and -397 PvuII&z.ast;C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod 13: 117-122, 2007.
167. Luisi S, Galleri L, Marini F, Ambrosini G, Brandi ML and Petraglia F: Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis. Fertil Steril 85: 764-766, 2006. (Pubitemid 43261583)
168. Kim SH, Choi YM, Jun JK, Kim SH, Kim JG and Moon SY: Estrogen receptor dinucleotide repeat polymorphism is associated with minimal or mild endometriosis. Fertil Steril 84: 774-777, 2005.
169. Kitawaki J, Obayashi H, Ishihara H, et al: Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Hum Reprod 16: 51-55, 2001. (Pubitemid 32058578)
170. Georgiou I, Syrrou M, Bouba I, et al: Association of estrogen receptor gene polymorphisms with endometriosis. Fertil Steril 72: 164-166, 1999. (Pubitemid 29300280)
171. Silva RC, Costa IR, Bordin BM, et al: RsaI polymorphism of the ERβ gene in women with endometriosis. Genet Mol Res 10: 465-470, 2011.
172. Zulli K, Bianco B, Mafra FA, Teles JS, Christofolini DM and Barbosa CP: Polymorphism of the estrogen receptor β gene is related to infertility and infertility-associated endometriosis. Arq Bras Endocrinol Metabol 54: 567-571, 2010.
173. Bianco B, Christofolini DM, Mafra FA, Brandes A, Zulli K and Barbosa CP: +1730 G/A polymorphism of the estrogen receptor beta gene (ERbeta) may be an important genetic factor predisposing to endometriosis. Acta Obstet Gynecol Scand 88: 1397-1401, 2009.
174. Wang Z, Yoshida S, Negoro K, Kennedy S, Barlow D and Maruo T: Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population. Fertil Steril 81: 1650-1656, 2004. (Pubitemid 38749012)
175. Tsuchiya M, Nakao H, Katoh T, et al: Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum Reprod 20: 974-978, 2005. (Pubitemid 40667843)
176. Hu X, Zhou Y, Feng Q, et al: Association of endometriosis risk and genetic polymorphisms involving biosynthesis of sex steroids and their receptors: an updating meta-analysis. Eur J Obstet Gynecol Reprod Biol 164: 1-9, 2012.
177. Wang HS, Cheng BH, Wu HM, et al: A mutant single nucleotide polymorphism of follicle-stimulating hormone receptor is associated with a lower risk of endometriosis. Fertil Steril 95: 455-457, 2011.
178. Mafra FA, Bianco B, Christofolini DM, Souza AM, Zulli K and Barbosa CP: Luteinizing hormone beta-subunit gene (LHbeta) polymorphism in infertility and endometriosis-associated infertility. Eur J Obstet Gynecol Reprod Biol 151: 66-69, 2010.
179. Caballero V, Ruiz R, Sainz JA, et al: Preliminary molecular genetic analysis of the receptor interacting protein 140 (RIP140) in women affected by endometriosis. J Exp Clin Assist Reprod 2: 11, 2005.
180. Costa IR, Silva RC, Frare AB, et al: Polymorphism of the progesterone receptor gene associated with endometriosis in patients from Goiás, Brazil. Genet Mol Res 10: 1364-1370, 2011.
181. De Carvalho CV, Nogueira-De-Souza NC, Costa AM, et al: Genetic polymorphisms of cytochrome P450cl7alpha (CYP17) and progesterone receptor genes (PROGINS) in the assessment of endometriosis risk. Gynecol Endocrinol 23: 29-33, 2007.
182. van Kaam KJ, Romano A, Schouten JP, Dunselman GA and Groothuis PG: Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis. Hum Reprod 22: 129-135, 2007. (Pubitemid 44942676)
183. Lattuada D, Somigliana E, Viganò P, Candiani M, Pardi G and Di Blasio AM: Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS? Clin Endocrinol (Oxf) 61: 190-194, 2004. (Pubitemid 39093113)
184. Wieser F, Schneeberger C, Tong D, Tempfer C, Huber JC and Wenzl R: PROGINS receptor gene polymorphism is associated with endometriosis. Fertil Steril 77: 309-312, 2002. (Pubitemid 34083553)
185. Ruiz LA, Dutil J, Ruiz A, et al: Single-nucleotide polymorphisms in the lysyl oxidase-like protein 4 and complement component 3 genes are associated with increased risk for endometriosis and endometriosis-associated infertility. Fertil Steril 96: 512-515, 2011.
186. Trovó de Marqui AB: Genetic polymorphisms and endometriosis: contribution of genes that regulate vascular function and tissue remodeling. Rev Assoc Med Bras 58: 620-632, 2012 (In English, Portuguese).
187. Shan K, Ying W, Jian-Hui Z, Wei G, Na W and Yan L: The function of the SNP in the MMP1 and MMP3 promoter in susceptibility to endometriosis in China. Mol Hum Reprod 11: 423-427, 2005. (Pubitemid 41418066)
188. Tsai EM, Wang YS, Lin CS, et al: A microRNA-520 mirSNP at the MMP2 gene influences susceptibility to endometriosis in Chinese women. J Hum Genet 58: 202-209, 2013.
189. Cho YJ, Kim NH, Jeong KA, et al: Association between MMP-2 and TIMP-2 gene polymorphisms and advanced-stage endometriosis in Korean women. Am J Reprod Immunol 69: 73-84, 2013.
190. Saare M, Lamp M, Kaart T, et al: Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis. Fertil Steril 94: 1560-1563, 2010.
191. Shan K, Lian-Fu Z, Hui D, et al: Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China. Mol Hum Reprod 12: 35-39, 2006.
192. Han YJ, Kim HN, Yoon JK, et al: Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced-stage endometriosis. Fertil Steril 91: 2324-2330, 2009.
193. Borghese B, Chiche JD, Vernerey D, et al: Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression. Hum Reprod 23: 1207-1213, 2008. (Pubitemid 351757308)
194. Gonçalves-Filho RP, Brandes A, Christofolini DM, Lerner TG, Bianco B and Barbosa CP: Plasminogen activator inhibitor-1 4G/5G polymorphism in infertile women with and without endometriosis. Acta Obstet Gynecol Scand 90: 473-477, 2011.
195. Bedaiwy MA, Falcone T, Mascha EJ and Casper RF: Genetic polymorphism in the fibrinolytic system and endometriosis. Obstet Gynecol 108: 162-168, 2006. (Pubitemid 44336860)
196. Kang S, Zhao XW, Wang N, Chen SC, Zhou RM and Li Y: Association of polymorphisms of the MMP-2 and TIMP-2 genes with the risk of endometriosis in North Chinese women. Fertil Steril 90: 2023-2029, 2008.
197. Zhang QY, Guan Q, Wang Y, et al: BDNF Val66Met polymorphism is associated with Stage III-IV endometriosis and poor in vitro fertilization outcome. Hum Reprod 27: 1668-1675, 2012.
198. Kim H, Park JH, Ku SY, Kim SH, Choi YM and Kim JG: Association between endometriosis and polymorphisms in insulin-like growth factors (IGFs) and IGF-I receptor genes in Korean women. Eur J Obstet Gynecol Reprod Biol 156: 87-90, 2011.
199. Kim H, Ku SY, Kim SH, Choi YM and Kim JG: Association between endometriosis and polymorphisms in insulin-like growth factor binding protein genes in Korean women. Eur J Obstet Gynecol Reprod Biol 162: 96-101, 2012.
200. Cayan F, Ertunç D, Aras-Ateş N, et al: Association of G1057D variant of insulin receptor substrate-2 with endometriosis. Fertil Steril 94: 1622-1626, 2010.
201. Kang S, Li SZ, Wang N, et al: Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women. Hum Reprod 25: 1806-1811, 2010.
202. Hsieh YY, Chang CC, Tsai FJ, Lin CC and Tsai CH: T homozygote and allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas. Fertil Steril 83: 796-799, 2005. (Pubitemid 40348606)
203. Vanaja MC, Rozati R, Nassaruddin K and Vishnupriya S: Association of VEGF +405G>C polymorphism with endometriosis. Front Biosci (Elite Ed) 5: 748-754, 2013.
204. Xu S, Wu W, Sun H, et al: Association of the vascular endothelial growth factor gene polymorphisms (-460C/T, +405G/C and +936T/C) with endometriosis: a meta-analysis. Ann Hum Genet 76: 464-471, 2012.
205. Emamifar B, Salehi Z, Mehrafza M and Mashayekhi F: The vascular endothelial growth factor (VEGF) polymorphisms and the risk of endometriosis in northern Iran. Gynecol Endocrinol 28: 447-450, 2012.
206. Lamp M, Saare M, Laisk T, et al: Genetic variations in vascular endothelial growth factor but not in angiotensin I-converting enzyme genes are associated with endometriosis in Estonian women. Eur J Obstet Gynecol Reprod Biol 153: 85-89, 2010.
207. Attar R, Agachan B, Kuran SB, et al: Genetic variants of vascular endothelial growth factor and risk for the development of endometriosis. In Vivo 24: 297-301, 2010.
208. Liu Q, Li Y, Zhao J, et al: Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women. Hum Reprod 24: 2660-2666, 2009.
209. Kim SH, Choi YM, Choung SH, Jun JK, Kim JG and Moon SY: Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 20: 2904-2908, 2005. (Pubitemid 41487650)
210. Bhanoori M, Arvind Babu K, Pavankumar Reddy NG, et al: The vascular endothelial growth factor (VEGF) +405G>C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod 20: 1844-1849, 2005. (Pubitemid 40932366)
211. Hsieh YY, Chang CC, Tsai FJ, Yeh LS, Lin CC and Peng CT: T allele for VEGF gene-460 polymorphism at the 5′-untranslated region: association with a higher susceptibility to endometriosis. J Reprod Med 49: 468-472, 2004.
212. Kang S, Shi YY, Li Y, et al: Association between genetic variants of the VEGFR-2 gene and the risk of developing endometriosis in Northern Chinese Women. Gynecol Obstet Invest 76: 32-37, 2013.
213. Camargo-Kosugi CM, da Silva ID, Sato H, et al: The V109G polymorphism in the p27 gene is associated with endometriosis. Eur J Obstet Gynecol Reprod Biol 145: 180-183, 2009.
214. Pagliardini L, Gentilini D, Vigano' P, et al: An Italian association study and meta-analysis with previous GWAS confirm WNT4, CDKN2BAS and FN1 as the first identified susceptibility loci for endometriosis. J Med Genet 50: 43-46, 2013.
215. Uno S, Zembutsu H, Hirasawa A, et al: A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet 42: 707-710, 2010.
216. Shi S, Zhou B, Zhang K and Zhang L: Association between two single nucleotide polymorphisms of PDCD6 gene and increased endometriosis risk. Hum Immunol 74: 215-218, 2013.
217. Gomes FM, Bianco B, Teles JS, et al: PTPN22 C1858T polymorphism in women with endometriosis. Am J Reprod Immunol 63: 227-232, 2010.
218. Ammendola M, Bottini N, Pietropolli A, Saccucci P and Gloria-Bottini F: Association between PTPN22 and endometriosis. Fertil Steril 89: 993-994, 2008. (Pubitemid 351491208)
219. Paskulin DD, Cunha-Filho JS, Souza CA, Bortolini MC, Hainaut P and Ashton-Prolla P: TP53 PIN3 and PEX4 polymorphisms and infertility associated with endometriosis or with post-in vitro fertilization implantation failure. Cell Death Dis 3: e392, 2012.
220. Gallegos-Arreola MP, Valencia-Rodríguez LE, Puebla-Pérez AM, Figuera LE and Zúñiga-González GM: The TP53 16-bp duplication polymorphism is enriched in endometriosis patients. Gynecol Obstet Invest 73: 118-123, 2012.
221. Jia S, Xu L, Chan Y, et al: p53 codon 72 polymorphism and endometriosis: a meta-analysis. Arch Gynecol Obstet 285: 1657-1661, 2012.
222. Ribeiro Júnior CL, Arruda JT, Silva CT and Moura KK: Analysis of p53 codon 72 gene polymorphism in Brazilian patients with endometriosis. Genet Mol Res 8: 494-499, 2009.
223. Hsieh YY and Lin CS: P53 codon 11, 72, and 248 gene polymorphisms in endometriosis. Int J Biol Sci 2: 188-193, 2006.
224. Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai HD and Lin CC: The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril 77: 43-45, 2002. (Pubitemid 34093891)
225. Bhanoori M, Deenadayal M, Kennedy S and Shivaji S: The G2964A 3′-untranslated region polymorphism of the signal transducer and activator of transcription 6 gene is associated with endometriosis in South Indian women. Hum Reprod 22: 1026-1030, 2007.
226. Yoshida K, Yoshihara K, Adachi S, et al: Possible involvement of the E-cadherin gene in genetic susceptibility to endometriosis. Hum Reprod 27: 1685-1689, 2012.
227. Govatati S, Tangudu NK, Deenadayal M, Chakravarty B, Shivaji S and Bhanoori M: Association of E-cadherin single nucleotide polymorphisms with the increased risk of endometriosis in Indian women. Mol Hum Reprod 18: 280-287, 2012.
228. Shan K, Xiao-Wei M, Na W, et al: Association of three single nucleotide polymorphisms of the E-cadherin gene with endometriosis in a Chinese population. Reproduction 134: 373-378, 2007. (Pubitemid 47278809)
229. Aghajanpour L, Mashayekhi F and Rajaei F: Intercellular adhesion molecule-1 (ICAM-1) gene polymorphism and endometriosis in northern Iran. Arch Gynecol Obstet 283: 1035-1039, 2011.
230. Chang CY, Chen Y, Lin WC, et al: MUC2 polymorphisms are associated with endometriosis development and infertility: a case-control study. BMC Med Genet 13: 15, 2012.
231. Chang CY, Chang HW, Chen CM, et al: MUC4 gene polymorphisms associate with endometriosis development and endometriosis-related infertility. BMC Med 9: 19, 2011.
232. Falconer H, Sundqvist J, Xu H, et al : Analysis of common variations in tumor-suppressor genes on chr1p36 among Caucasian women with endometriosis. Gynecol Oncol 127: 398-402, 2012.
233. Wu HH, Wang NM, Lin CY and Tsai HD: Genetic alterations of HOXA10 and their effect on the severity of endometriosis in a Taiwanese population. Reprod Biomed Online 16: 416-424, 2008. (Pubitemid 351419462)
234. Hwang KR, Choi YM, Kim JM, et al: Association of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism with advanced-stage endometriosis. Am J Reprod Immunol 64: 333-338, 2010.
235. Kiyomizu M, Kitawaki J, Obayashi H, et al: Association of two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene with adenomyosis, endometriosis, and leiomyomata in Japanese women. J Soc Gynecol Investig 13: 372-377, 2006. (Pubitemid 43928658)
236. Ishii K, Takakuwa K, Kashima K, Tamura M and Tanaka K: Associations between patients with endometriosis and HLA class II; the analysis of HLA-DQB1 and HLA-DPB1 genotypes. Hum Reprod 18: 985-989, 2003. (Pubitemid 36603264)
237. Ishii K, Takakuwa K, Mitsui T and Tanaka K: Studies on the human leukocyte antigen-DR in patients with endometriosis: genotyping of HLA-DRB1 alleles. Hum Reprod 17: 560-563, 2002. (Pubitemid 34232420)
238. Grechukhina O, Petracco R, Popkhadze S, et al: A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis. EMBO Mol Med 4: 206-217, 2012.
239. Hsieh YY, Lee CC, Chang CC, Wang YK, Yeh LS and Lin CS: Angiotensin I-converting enzyme insertion-related genotypes and allele are associated with higher susceptibility of endometriosis and leiomyoma. Mol Reprod Dev 74: 808-814, 2007.
240. Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin CC and Tsai CH: Angiotensin I-converting enzyme ACE 2350&z.ast;G and ACE-240&z.ast;T-related genotypes and alleles are associated with higher susceptibility to endometriosis. Mol Hum Reprod 11: 11-14, 2005. (Pubitemid 40330997)
241. Kim JG, Kim H, Ku SY, et al: Association between human alpha 2-Heremans Schmidt glycoprotein (AHSG) polymorphism and endometriosis in Korean women. Fertil Steril 82: 1497-1500, 2004. (Pubitemid 39611372)
242. Borghese B, Santulli P, Héquet D, et al: Genetic polymorphisms of DNMT3L involved in hypermethylation of chromosomal ends are associated with greater risk of developing ovarian endometriosis. Am J Pathol 180: 1781-1786, 2012.
243. Szczepańska M, Mostowska A, Wirstlein P, et al: Polymorphic variants of folate and choline metabolism genes and the risk of endometriosis-associated infertility. Eur J Obstet Gynecol Reprod Biol 157: 67-72, 2011.
244. Zhao ZZ, Croft L, Nyholt DR, et al: Evaluation of polymorphisms in predicted target sites for micro RNAs differentially expressed in endometriosis. Mol Hum Reprod 17: 92-103, 2011.
245. Chun S, Kim H, Ku SY, Suh CS, Kim SH and Kim JG: The association between endometriosis and polymorphisms in the interleukin-1 family genes in Korean women. Am J Reprod Immunol 68: 154-163, 2012.
246. Viganò P, Infantino M, Lattuada D, et al: Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis. Mol Hum Reprod 9: 47-52, 2003.